NCT00212615View on ClinicalTrials.gov

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
C04.588.274.476.411.307
Interventions
DRUG

Oxaliplatin (Eloxatin)

DRUG

Capecitabine (Xeloda)

Trial Locations (8)

2730

Department of Oncology, Herlev University Hospital, Herlev

3400

Department of Oncology, Hillerød Hospital, Hillerød

4000

Department of Oncology, Roskilde Hospital, Roskilde

4700

Department of Oncology, Næstved Hospital, Næstved

6700

Department of Oncology, Esbjerg Hospital, Esbjerg

7400

Department of Oncology, Herning Hospital, Herning

100 26

Department of Oncology, Radiumhemmet, Stockholm

751 85

Department of Oncology, Uppsala University Hospital, Uppsala

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT00212615 - XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter